Electrocardiographic Left Ventricular Hypertrophy Regression Induced by an Angiotensin Receptor Blocker-Based Regimen in Hypertensive Patients With the Metabolic Syndrome: Data From the SARA Study-Reference-Cited by-同舟云学术

Electrocardiographic Left Ventricular Hypertrophy Regression Induced by an Angiotensin Receptor Blocker-Based Regimen in Hypertensive Patients With the Metabolic Syndrome: Data From the SARA Study

Published:2008-03 Issue:3 Volume:10 Page:208-214
ISSN:1524-6175
Container-title:The Journal of Clinical Hypertension
language:en
Short-container-title:J Clin Hypertension

Author:

Escobar Carlos,Barrios Vivencio,Calderón Alberto,Barrios Sara,Echarri Rocio,Navarro-Cid Josefa,Ferrer Elena,Fernandez Raúl

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference40 articles.

1. Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study

2. Risk Constellations in Patients with the Metabolic Syndrome: Epidemiology, Diagnosis, and Treatment Patterns

3. Global and societal implications of the diabetes epidemic

4. Metabolic syndrome and target organ damage in untreated essential hypertensives

5. Age and Target Organ Damage in Essential Hypertension: Role of the Metabolic Syndrome

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin II-Induced Signal Transduction Mechanisms for Cardiac Hypertrophy;Cells;2022-10-22

2. CANDESARTAN IN CARDIOLOGY PRACTICE;Medical Council;2017-12-30

3. High serum uric acid levels may increase mortality and major adverse cardiovascular events in patients with acute myocardial infarction;Saudi Medical Journal;2017-06

4. Nephro- and Cerebroprotection in Chronic Kidney Diseases: Candesartan's Potential;KARDIOLOGIYA;2017

5. Candesartan in treating hypertension;Systemic Hypertension;2014-03-15